Oljuskin Timur, Azodi Nazli, Volpedo Greta, Bhattacharya Parna, Markle Hannah L, Hamano Shinjiro, Matlashewski Greg, Satoskar Abhay R, Gannavaram Sreenivas, Nakhasi Hira L
Animal Parasitic Diseases Laboratory, Agricultural Research Service, USDA, Beltsville, MD 20705, USA.
Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD 20993, USA.
iScience. 2023 Aug 29;26(9):107593. doi: 10.1016/j.isci.2023.107593. eCollection 2023 Sep 15.
Leishmaniasis is a parasitic disease that is prevalent in 90 countries, and yet no licensed human vaccine exists against it. Toward control of leishmaniasis, we have developed gene deletion mutant strains () as a live attenuated vaccine, which induces a strong IFN-γ-mediated protection to the host. However, the immune mechanisms of such protection remain to be understood. Metabolomic reprogramming of the host cells following infection has been shown to play a critical role in pathogenicity and shaping the immune response following infection. Here, we applied untargeted mass spectrometric analysis to study the metabolic changes induced by infection with and compared those with virulent parasite infection to identify the immune mechanism of protection. Our data show that immunization with parasites, in contrast to virulent infection promotes a pro-inflammatory response by utilizing tryptophan to produce melatonin and downregulate anti-inflammatory kynurenine-AhR and FICZ-AhR signaling.
利什曼病是一种在90个国家流行的寄生虫病,但目前尚无针对它的获批人用疫苗。为了控制利什曼病,我们开发了基因缺失突变株作为减毒活疫苗,它能诱导宿主产生强烈的IFN-γ介导的保护作用。然而,这种保护的免疫机制仍有待了解。已证明感染利什曼原虫后宿主细胞的代谢重编程在致病性以及塑造感染后的免疫反应中起关键作用。在此,我们应用非靶向质谱分析来研究利什曼原虫感染诱导的代谢变化,并将其与强毒利什曼原虫感染进行比较,以确定保护的免疫机制。我们的数据表明,与强毒感染相比,用利什曼原虫免疫通过利用色氨酸产生褪黑素并下调抗炎性犬尿氨酸-AhR和FICZ-AhR信号来促进促炎反应。